Market Tracker

08/26 5:16pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

23.94
Delayed Data
As of Aug 26
 +0.11 / +0.46%
Today’s Change
20.97
Today|||52-Week Range
46.10
-44.01%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close23.83
Today’s open24.01
Day’s range23.62 - 24.52
Volume834,912
Average volume (3 months)822,652
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+9.81%
Earnings growth (next 5 years)+19.19%
Revenue growth (last year)+44.36%
P/E ratio49.9
Price/Sales3.58
Price/Book1.63

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.70+1.76%
PRTAProthena Corporation...+0.65+1.32%
PBYIPuma Biotechnology I...+0.68+1.19%
ALDRAlder Biopharmaceuti...+0.59+1.85%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts